1Kirpensteijn J,Teske E,Kik M. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma a phase II evaluation[J].{H}Anticancer Research,2002,(5):2765-2770.
2周建农.肿瘤药物治疗手册[M]{H}南京:东南大学出版社,2005125-131.
3Chua TC, Esquivel J, Pelz JO, et al. Summary of current therapeutic options for peritoneal metastases from colorectal cancer[J]. J Surg oncol, 2013, 107(6): 566-73.
4Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis[J]. J Surg oncol, 2010, 101(8): 713-24.
5Glehen O, Osinsky D, Cot te E, et al. Int raperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures[J]. Ann Surg Oncol, 2003, 10(8): 863-9.
6Elias D, Bonnay M, Puizillou JM, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution[J]. Ann Oncol, 2002, 13(2): 267-72.
7El-Kareh AW, Secomb TW. A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance[J]. Neoplasia, 2004, 6(2): 117-27.
8Huang CQ, Feng JP, Yang X, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center[J]. J Surg Oncol, 2014,109(7): 730-9.
9Coccolini F, Campanati L, Catena F, et al. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study[J]. J Gynecol Oncol, 2015, 26(1): 54-61.
10Ali I, Wani WA, Saleem K, et al. Platinum compouds: a hope for future cancer chemotherapy[J]. Anticancer Agents Med Chem,2013, 13(2): 296-306.
